GloPID-R is delighted to announce that the European & Developing Countries Clinical Trials Partnership (EDCTP) is now a member of the GloPID-R network. The EDCTP will be represented by Pauline Beattie and joins WHO and CEPI as an observer organization.
Welcoming the EDCTP, GloPID-R Vice-chair, Charu Kaushic stated “The EDCTP is a valuable addition to our network. Their expertise in funding research in sub-Saharan Africa will be a great asset to the GloPID-R community”.
The EDCTP is a public-public partnership. 14 countries from Europe and 16 from sub-Saharan Africa make up the EDCTP membership. Its role is to fund clinical research for medical tools to detect, treat and prevent poverty-related infectious diseases, including (re-) emerging diseases, in sub-Saharan Africa. The EDCTP achieves this through the development of clinical research capacity. Founded in 2003, EDCTP, with its partners, have made numerous investments for research preparedness and response to infectious disease outbreaks.
In response to the COVID-19 pandemic, the EDCTP activated its ‘Emergency funding mechanism’ to ensure that COVID-19 research in sub-Saharan Africa began rapidly. A record number of applications were submitted to this call and an accelerated review mechanism was implemented to select the 20 proposals selected from 100 eligible applications.
Executive Director of the EDCTP, Michael Makanga commented: “The EDCTP is delighted to join the GloPID-R network. We firmly believe in developing international partnerships to ensure that the financing of preparedness for rapid research response remains a priority in sub-Saharan Africa and across the globe.”
The EDCTP programme is supported under Horizon 2020, the European Union’s Framework Programme for Research and Innovation. EDCTP member countries contribute directly and indirectly and support is received from charitable organisations, companies and other partners.Back